BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36478459)

  • 21. Nomogram predicting the risk of three-year chronic kidney disease adverse outcomes among East Asian patients with CKD.
    Ye H; Chen Y; Ye P; Zhang Y; Liu X; Xiao G; Zhang Z; Kong Y; Liang G
    BMC Nephrol; 2021 Sep; 22(1):322. PubMed ID: 34579654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of short warm ischemic time on longitudinal kidney function and survival rate after partial nephrectomy for renal cell carcinoma in patients with pre-existing chronic kidney disease stage III: A multi-institutional propensity score-matched study.
    Chung JS; Hong SK; Lee SC; Jeong CW; Kwak C; Kim HH; Hong SH; Kim YJ; Kang SH; Chung J; Kwon TG; Hwang EC; Byun SS
    Eur J Surg Oncol; 2021 Feb; 47(2):470-476. PubMed ID: 32631709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of chronic kidney disease after orthotopic liver transplantation: development and validation of a nomogram model.
    Guo D; Wang H; Liu J; Liu H; Zhang M; Fu Z; Liu X
    BMC Nephrol; 2022 Jan; 23(1):33. PubMed ID: 35034618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of a nomogram model for predicting chronic kidney disease after liver transplantation: a multi-center retrospective study.
    He Z; Lin Y; Dong S; Ke Q; Zheng S; Ling Q
    Sci Rep; 2023 Jul; 13(1):11380. PubMed ID: 37452094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of progression to end-stage renal disease requiring dialysis after partial or radical nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease.
    Takagi T; Kondo T; Omae K; Iizuka J; Kobayashi H; Yoshida K; Hashimoto Y; Tanabe K
    Int Urol Nephrol; 2016 Sep; 48(9):1421-7. PubMed ID: 27193433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of survival for patients with chronic kidney disease primarily related to renal cancer surgery.
    Wu J; Suk-Ouichai C; Dong W; Antonio EC; Derweesh IH; Lane BR; Demirjian S; Li J; Campbell SC
    BJU Int; 2018 Jan; 121(1):93-100. PubMed ID: 28834125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. External validation of a nomogram including the computed tomography imaging score to predict indolent renal masses.
    Chen X; Wan B; Yang D; Zhao H; Tan W
    Int Urol Nephrol; 2017 Jul; 49(7):1119-1126. PubMed ID: 28417341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and validation of a novel nomogram to predict overall survival of patients with moderate to severe chronic kidney disease.
    Li N; Zhou G; Zheng Y; Zhou E; He W; Sun W; Zhang L
    Ren Fail; 2022 Jan; 44(1):241-249. PubMed ID: 35166166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is partial nephrectomy worth performing compared to radical nephrectomy for small, localised renal cortical tumours in geriatric patients?
    Lam JKJ; Tan SY; Chong KT
    Singapore Med J; 2020 Apr; 61(4):190-193. PubMed ID: 31680178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parenchymal Volumetric Assessment as a Predictive Tool to Determine Renal Function Benefit of Nephron-Sparing Surgery Compared with Radical Nephrectomy.
    Liss MA; DeConde R; Caovan D; Hofler J; Gabe M; Palazzi KL; Patel ND; Lee HJ; Ideker T; Van Poppel H; Karow D; Aertsen M; Casola G; Derweesh IH
    J Endourol; 2016 Jan; 30(1):114-21. PubMed ID: 26192380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting Renal Function Outcomes After Partial and Radical Nephrectomy.
    Bhindi B; Lohse CM; Schulte PJ; Mason RJ; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2019 May; 75(5):766-772. PubMed ID: 30477983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic Kidney Disease After Partial Nephrectomy in Patients With Preoperative Inconspicuous Renal Function - Curiosity or Relevant Issue?
    Nientiedt M; Bertolo R; Campi R; Capitanio U; Erdem S; Kara Ö; Klatte T; Larcher A; Mir MC; Ouzaid I; Roussel E; Salagierski M; Waldbillig F; Kriegmair MC
    Clin Genitourin Cancer; 2020 Dec; 18(6):e754-e761. PubMed ID: 32660879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients with medical risk factors for chronic kidney disease are at increased risk of renal impairment despite the use of nephron-sparing surgery.
    Satasivam P; Reeves F; Rao K; Ivey Z; Basto M; Yip M; Roth H; Grummet J; Goad J; Moon D; Murphy D; Appu S; Lawrentschuk N; Bolton D; Kearsley J; Costello A; Frydenberg M
    BJU Int; 2015 Oct; 116(4):590-5. PubMed ID: 25676543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New Chronic Kidney Disease and Overall Survival After Nephrectomy for Small Renal Cortical Tumors.
    Mashni JW; Assel M; Maschino A; Russo M; Masi B; Bernstein M; Huang WC; Russo P
    Urology; 2015 Dec; 86(6):1137-43. PubMed ID: 26362947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating the risk of chronic kidney disease after nephrectomy.
    Ngo TC; Hurley MP; Thong AE; Jeon SH; Leppert JT; Chung BI
    Can J Urol; 2013 Dec; 20(6):7035-41. PubMed ID: 24331345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative nomogram predicting 12-year probability of metastatic renal cancer - evaluation in a contemporary cohort.
    Mano R; Duzgol C; Ganat M; Goldman DA; Blum KA; Silagy AW; Walasek A; Sanchez A; DiNatale RG; Marcon J; Kashan M; Becerra MF; Benfante N; Coleman JA; Kattan MW; Russo P; Akin O; Ostrovnaya I; Hakimi AA
    Urol Oncol; 2020 Nov; 38(11):853.e1-853.e7. PubMed ID: 32900625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of worsening surgically induced chronic kidney disease (CKD-S) in preoperative CKD-naïve patients on survival in renal cell carcinoma.
    Nguyen MV; Walia A; Saidian A; Puri D; Meagher MF; Hakimi K; Tanaka H; Patil D; Yasuda Y; Saito K; Dhanji S; Cerrato C; Narasimhan R; Perry J; Master V; Fujii Y; Derweesh IH
    BJU Int; 2023 Feb; 131(2):219-226. PubMed ID: 35876044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Should partial nephrectomy be considered "elective" in patients with stage 2 chronic kidney disease? A comparative analysis of functional and survival outcomes after radical and partial nephrectomy.
    Hamilton ZA; Capitanio U; Lane BR; Larcher A; Yim K; Dey S; Cotta BH; Meagher MF; Kirmiz S; Bezinque A; Eldefrawy A; Bradshaw A; Ryan S; Carenzi C; Wan F; Proudfoot J; Montorsi F; Derweesh IH
    World J Urol; 2019 Nov; 37(11):2429-2437. PubMed ID: 30710156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of anatomic and morphologic nomogram to predict malignant and high-grade disease in a cohort of patients with small renal masses.
    Bagrodia A; Harrow B; Liu ZW; Olweny EO; Faddegon S; Yin G; Tan YK; Han WK; Lotan Y; Margulis V; Cadeddu JA
    Urol Oncol; 2014 Jan; 32(1):37.e17-23. PubMed ID: 23628308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive Management of Renal Masses in Solitary Kidneys.
    Yasuda Y; Zhang JH; Attawettayanon W; Rathi N; Wilkins L; Roversi G; Zhang A; Accioly JPE; Shah S; Munoz-Lopez C; Palacios DA; Hofmann M; Campbell RA; Kaouk J; Haber GP; Eltemamy M; Krishnamurthi V; Abouassaly R; Martin C; Li J; Weight C; Campbell SC
    Eur Urol Oncol; 2023 Feb; 6(1):84-94. PubMed ID: 36517406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.